B2M and breast cancer: Interestingly, mutations in the B2M gene have not been reported in BC, although the total absence of HLA-I molecules is quite high, mostly due to a coordinated downregulation of HLA and APM molecules or epigenetic alterations along with altered oncogenic and IFN-gamma signaling [41,42,43].